Business
Akebia Therapeutics to Host Stockholder Information Session to Discuss Rationale for Reverse Stock Split
Webcast Scheduled for Friday, April 21 at 8:00 a.m. ET Stockholders are invited to submit questions in advance CAMBRIDGE, Mass., April 14, 2023 /PRNewswire/
About this update from Akebia Therapeutics, Inc.
[{"type":"text","content":"Webcast Scheduled for Friday, April 21 at 8:00 a.m. ET\nStockholders are invited to submit questions in advance\nCAMBRIDGE, Mass., April 14, 2023 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that it will host a stockholder information session on Friday, April 21 at 8:00 a.m. ET to discuss its upcoming special meeting of stockholders (Special Meeting) to seek stockholder approval to, among other things, effect a reverse stock split of Akebia's outstanding common stock, which Akebia believes would allow it to regain compliance with the Nasdaq Stock Market's (Nasdaq) minimum bid price rule and avoid delisting.\n\n \n \n \n \n \n \n\n \nA letter to stockholders to discuss the reverse stock split proposal will be available via the Investors section of Akebia's website at: https://ir.akebia.com/.\nThe Special Meeting is being held on Thursday, May 4 at 10:00 a.m. ET at www.virtualshareholdermeeting.com/AKBA2023SM. The record date for the Special Meeting continues to be the close of business on February 16, 2023. Akebia's board of directors strongly recommends that stockholders vote \"FOR\" each of the proposals presented at the Special Meeting.\nIf you need assistance in voting your shares or have questions regarding the Special Meeting, please contact Akebia's proxy solicitor, MacKenzie Partners, Inc., at (800) 322-2885 (toll-free) or (212) 929-5500 (collect), or by email at [email protected].\nStockholders are invited to register for the webcast and to submit questions in advance for Akebia leadership to address during the Stockholder Information Session. To submit a question, stockholders should email [email protected] by Wednesday, April 19 and include the subject line: Question for Stockholder Information Session.\nWebcast Registration \nA live webcast of Akebia's Stockholder Information Session will be available via the Investors section of Akebia's website at: https://ir.akebia.com/ or click here to register.\nAn online archive and a transcript of the webcast will be available via the Investors section of Akebia's website at http://ir.akebia.com following the live webcast.\nAdditional Information and Exercising Your Vote \nOn March 17, 2023, Akebia filed with the SEC revised proxy materials, ...